Gloria Pharma Invests $40 Million In Proteus Digital Health, Inc.; Gains Option For China JV

Gloria Pharma of Harbin, China will invest $40 million in Proteus Digital Health, a US company with a remote patient monitoring device. As a sweetener for the investment, Gloria will have an exclusive 18-month option to form a China JV with Proteus. Proteus expects to raise a total of $110 million in its current H funding round. Gloria will purchase $25 million of Proteus' preferred stock, and will invest another $15 million through Shanghai Sailing Boda Equity Investment Fund Partnership.